1Riche DM, East HE, Riche KD. Impact of sitagliptin on markers of beta-cell function: a meta analysis[J]. Am J Med Sci, 2009, 337(5): 321 -328.
2Mu J, Petrov A, Eiermann GJ, et al. Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes[J]. Eur J Pharmacol,2009,623 (1-3): 148-154.
3Aschner P,Katzerff HL,Guo H, et al. Efficacy and safety of monotherapy of sitagliptin compared with metformin in pa- tients with type 2 diabetes[J]. Diabetes Obes Metab,2010,12 (3) :252-261.
4Hallschmid M,Jauch-Chara K,Korn O,etal. Euglycemic infu- sion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects[J]. Diabe tes, 2010, 59(4): 1101-1107.
